Clinical Trials Sponsored by MSc Eylem Nazan KAPAN
Total 1 results
-
Ataturk UniversityMSc Eylem Nazan KAPANCompleted
Sponsors and Collaborators
- University Düsseldorf
- Grant from "Axiomedic. Advanced Medical Solutions", Zurich, Switzerland
- Stadt Homburg
- William R. Drobyski, MD
- Beijing Arion Cancer Center
- Mahmoud Awad Ramadan Elkholy
- Spineology, Inc
- French Society for Intensive Care
- Bone Cancer Research Trust
- Dawn Brewer
- Inozyme Pharma
- Yao Xie
- Dutch Transplantation Fund
- AFC (Association Francophone de Chirurgie)
- Atlanta Pediatric Device Consortium
- Catholic University of Health and Allied Sciences
- charbel najem
- Intersci Research Association, Austria
- Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital.
- Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group
- View Full List
Medical Conditions
- Postmenopause
- Allergic Diseases
- HIV Risk
- Efficacy of Trishul
- Progesteron
- Conflict Resolution Styles
- Polypectomy
- Diabetes Type I
- Paracetamol Toxicity
- Atrophic Nonunion of Fracture
- Allergic Conjunctivitis Due to Dermatophagoides Pteronyssinus
- Lower Limb Arterial Disease
- Pseudo Exfoliative Syndrome
- Prognostic Stage I Breast Cancer AJCC v8
- Neoadjuvant Non-Small Cell Lung Cancer
- Demyelination; Corpus Callosum
- Squamous Cell Carcinomas of the Head and Neck
- Traditional Rehabilitation After ACL Reconstruction Vs Training Vs Traditional Rehabilitation Plus Inertial Exercises
- Deficient Keratinized Mucosa
- Dental Pain and Sensation Disorder
- View Full List
Drug Interventions
- Pregabalin immediate release, 25 mg
- Aloe vera gel
- Melatonin 20 MG
- CKD-498 dose#2
- Vitamin B12
- Enoxaparin, Heparin
- Nirmatrelvir/Ritonavir
- Control group
- Alphagan
- Ferric derisomaltose
- Nigella sativa seeds extract containing ointment intervention
- Doxorubicin, Paclitaxel, Cisplatin
- BIIF 1149 BS
- S-2367 1600 mg
- Nab-paclitaxel
- Sequence 2 : Period 1 (VR 160/20 mg-2), Period 2 (V+R), Period 3 (VR 160/20 mg-1)
- Serdolect
- Lecitone®Se-Vitamin D3
- PA9159 Metered-Dose Inhaler, 240 μg per day for 28 days
- Zanubrutinib
- View Full List
CROs by country
- Contract Research Organizations in Benin
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Iran
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Poland
- Contract Research Organizations in Singapore
- Contract Research Organizations in Slovenia
- Contract Research Organizations in South Korea
- CRO list by country